Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, Qorbani M, Alavian SM, Daneshi-Maskooni M, Hosseinzadeh-Attar MJ. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. BMJ Open. 2017 Jul 1;7(7):e016914.
Article
PubMed
PubMed Central
Google Scholar
Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, Qorbani M, Alavian SM, Daneshi-Maskooni M, Hosseinzadeh-Attar MJ. The nanocurcumin reduces appetite in obese patients with non-alcoholic fatty liver disease (nafld): a double-blind randomized placebo-controlled clinical trial. Nanomedicine Journal. 2018;5(2):67–76.
CAS
Google Scholar
Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G. Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial. Nutrition & metabolism. 2018 Dec;15(1):63.
Article
CAS
Google Scholar
Daneshi-Maskooni M, Keshavarz SA, Mansouri S, Qorbani M, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial. Trials. 2017 Dec;18(1):260.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ayada C, Toru Ü, Korkut Y. Nesfatin-1 and its effects on different systems. Hippokratia. 2015;19:4.
CAS
PubMed
PubMed Central
Google Scholar
Başar O, Akbal E, Köklü S, et al. A novel appetite peptide, nesfatin-1 in patients with the non-alcoholic fatty liver disease. Scand J Clin Lab Invest. 2012;72:479–83.
Article
PubMed
CAS
Google Scholar
Dixon JB, Bhathal PS, Hughes NR, O’Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39:1647–54.
Article
PubMed
Google Scholar
Luyckx FH, Desaive C, Thiry A, Dewe W, Scheen AJ, Gielen JE, Lefebvre PJ. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord. 1998;22:222–6.
Article
CAS
PubMed
Google Scholar
Verma SK, Jain V, Singh DP. Effect of greater cardamom (Amomum subulatum Roxb.) on blood lipids, fibrinolysis and total antioxidant status in patients with ischemic heart disease. Asian Pacific J Trop Dis. 2012;2:S739–43.
Article
CAS
Google Scholar
Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990;99:1408–13.
Article
CAS
PubMed
Google Scholar
The lab tests online. Laboratory methods used for medical lab testing (enzyme-linked immunosorbent assay (ELISA)) [Internet]. 2012. [cited 26 Feb 2017]. Available from: https://labtestsonline.org/understanding/features/methods/start/2/. Accessed 26 Feb 2017.
Jazayeri S, Nouri M, Pour-Ebrahim R, Fakhrzadeh H, Larijani B. Food and nutrient intake status in urban population (20–60 years) of population research center of Tehran University of Medical Sciences. Iran J Diab Lipid. 2005;1(3):81–9 [in Farsi].
Google Scholar
Qaffarpour M, Houshyar-Rad A, Kianfar H. Guides of home scales, conversion coefficients and percentage of Iranian foods. Tehran: Agricultural Sciences Publication; 2000. [in Farsi]
Google Scholar
The IPAQ group. International Physical Activity Questionnaire [Internet]. 2017. [cited 26 Feb 2017]. Available from: https://sites.google.com/site/theipaq/.
Booth ML, Ainsworth BE, Pratt MI, Ekelund U, Yngve AG, Sallis JF, Oja PE. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;195(9131/03):3508–1381.
Google Scholar
Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, et al. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012;35:2121–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendía LE, Sahebkar A. Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug research. 2017 Apr;67(04):244–51.
Article
CAS
PubMed
Google Scholar
Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 2014 Feb 1;25(2):144–50.
Article
CAS
PubMed
Google Scholar
Panahi Y, Khalili N, Sahebi E, Namazi S, Karimian MS, Majeed M, Sahebkar A. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology. 2017 Feb 1;25(1):25–31.
Article
CAS
PubMed
Google Scholar
Hewlings SJ, Kalman DS. Curcumin: a review of its’ effects on human health. Foods. 2017 Oct 22;6(10):92.
Article
PubMed Central
CAS
Google Scholar
Lizana P, Galdames M, Rodrigo R. Oxidative stress and endoplasmic reticulum stress as potential therapeutic targets in non-alcoholic fatty liver disease. Reactive Oxygen Species. 2017;4(10):266–74.
Google Scholar
Navekar R, Rafraf M, Ghaffari A, Asghari-Jafarabadi M, Khoshbaten M. Turmeric supplementation improves serum glucose indices and leptin levels in patients with nonalcoholic fatty liver diseases. J Am Coll Nutr. 2017 May 19;36(4):261–7.
Article
CAS
PubMed
Google Scholar
Kocaadam B, Şanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017 Sep 2;57(13):2889–95.
Article
CAS
PubMed
Google Scholar
Jin T, Song Z, Weng J, Fantus IG. Curcumin and other dietary polyphenols: potential mechanisms of metabolic actions and therapy for diabetes and obesity. American Journal of Physiology-Endocrinology and Metabolism. 2018;314(3):E201–5. https://doi.org/10.1152/ajpendo.00285.2017.
Article
CAS
PubMed
Google Scholar
Hariri M, Haghighatdoost F. Effect of curcumin on anthropometric measures: a systematic review on randomized clinical trials. J Am Coll Nutr. 2018 Jan 8;37(3):215–22. https://doi.org/10.1080/07315724.2017.1392263.
Article
CAS
PubMed
Google Scholar
Shen P, Han Y, Cai B, Wang Y. Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome. Sleep and Breathing. 2015 May 1;19(2):515–22.
Article
PubMed
Google Scholar
Zhang DW, Fu M, Gao SH, Liu JL. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013;2013.
Syabaniarti AN. The Relationship between Body Mass Index (BMI) and Waist Circumference (WC) to fasting blood glucose level based on the medical check-up result of PT. X Regional Jakarta Employees Year 2016. 2nd International Seminar on Global Health (ISGH); 2018: 306–312. http://repository.stikesayani.ac.id/index.php/isgh2/article/view/66.
Dong J, Xu H, Wang PF, Cai GJ, Song HF, Wang CC, Dong ZT, Ju YJ, Jiang ZY. Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice. PLoS One. 2013 Dec 31;8(12):e83397.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kim SH, Ahn M, Jung IA, Jeon YJ, Cho WK, Cho KS, Park SH, Jung MH, Suh BK. The relation of serum Nesfatin-1 level with anthropometric and metabolic parameters in Korean children and young adolescents. ESPE Abstracts 2015; 84: P2–375. http://abstracts.eurospe.org/hrp/0084/hrp0084p2-375.htm.
Abaci A, Catli G, Anik A, Kume T, Bober E. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diabetes. 2013 May 1;14(3):189–95.
CAS
PubMed
Google Scholar
Hamedani NK, Hosseinzadeh-Attar MJ, Hosseini M. The correlation between nesfatin-1 and blood pressure in healthy normal weight and obese adults. International Research Journal of Applied and Basic Sciences. 2014;8(4):398–400.
Google Scholar
de Meloa IS, dos Santosb AF, Buenoc NB. Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2017 Sep 18;128:137–44. https://doi.org/10.1016/j.phrs.2017.09.010.
Article
CAS
Google Scholar
Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, Ghayour MM, Kazemi RO. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna journal of phytomedicine. 2016;6(5):567–77.
PubMed
PubMed Central
CAS
Google Scholar
Kim HG, Lee SB, Lee JS, Kim WY, Choi SH, Son CG. Artemisia iwayomogi plus Curcuma longa Synergistically Ameliorates Nonalcoholic Steatohepatitis in HepG2 Cells. Evidence-Based Complementary and Alternative Medicine. 2017; Article ID 4390636. 9 pages. Doi: https://doi.org/10.1155/2017/4390636.
Ghorbani Z, Hekmatdoost A, Mirmiran P. Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principal constituent curcumin. International journal of endocrinology and metabolism. 2014 Oct 1;12(4):e18081.
Article
PubMed
PubMed Central
Google Scholar
Panahi Y, Khalili N, Sahebi E, Namazi S, Reiner Ž, Majeed M, Sahbekar A. Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial. Complementary therapies in medicine. 2017 Aug 1;33:1–5.
Article
PubMed
Google Scholar
Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M, Ferns GA. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res. 2013 Mar 1;27(3):374–9.
Article
CAS
PubMed
Google Scholar
Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013 Jan 1;15(1):195–218.
Article
CAS
PubMed
Google Scholar
S Darvesh A, B Aggarwal B, Bishayee A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol. 2012 Jan 1;13(1):218–28.
Article
Google Scholar
Ballantyne M. The Pharmacognosy and Therapeutic Efficacy of Turmeric (Curcuma longa): A Systematic Review. Senior Honors Projects. 2017; Paper 573. http://digitalcommons.uri.edu/srhonorsprog/573
Kapakos G, Youreva V, Srivastava AK. Cardiovascular protection by curcumin: molecular aspects. Indian J Biochem Biophys. 2012 Oct;49(5):306–15.
CAS
PubMed
Google Scholar
Lopresti AL, Hood SD, Drummond PD. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. J Psychopharmacol. 2012 Dec;26(12):1512–24.
Article
CAS
PubMed
Google Scholar
Meng B, Li J, Cao H. Antioxidant and anti-inflammatory activities of curcumin on diabetes mellitus and its complications. Curr Pharm Des. 2013 Apr 1;19(11):2101–13.
CAS
PubMed
Google Scholar
Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: a review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother. 2017 Jan 1;85:102–12.
Article
CAS
PubMed
Google Scholar
Noorafshan A, Ashkani-Esfahani S. A review of the therapeutic effects of curcumin. Curr Pharm Des. 2013 Apr 1;19(11):2032–46.
CAS
PubMed
Google Scholar
Sahebkar A, Cicero AF, Simental-Mendía LE, Aggarwal BB, Gupta SC. Curcumin downregulates human tumor necrosis factor-α levels: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016 May 1;107:234–42.
Article
CAS
PubMed
Google Scholar
Shehzad A, Lee YS. Molecular mechanisms of curcumin action: signal transduction. Biofactors. 2013 Jan 1;39(1):27–36.
Article
CAS
PubMed
Google Scholar
Schlecht I, Fischer B, Behrens G, Leitzmann MF. Relations of visceral and abdominal subcutaneous adipose tissue, body mass index, and waist circumference to serum concentrations of parameters of chronic inflammation. Obesity facts. 2016;9(3):144–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stepanikova I, Oates GR, Bateman LB. Does one size fit all? The role of body mass index and waist circumference in systemic inflammation in midlife by race and gender. Ethnicity & health. 2017 Mar 4;22(2):169–83.
Article
Google Scholar
Panahi Y, Ahmadi Y, Teymouri M, Johnston TP, Sahebkar A. Curcumin as a potential candidate for treating hyperlipidemia: a review of cellular and metabolic mechanisms. J Cell Physiol. 2018 Jan 1;233(1):141–52.
Article
CAS
PubMed
Google Scholar
Qin S, Huang L, Gong J, Shen S, Huang J, Ren H, Hu H. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J. 2017;16(1):68. https://doi.org/10.1186/s12937-017-0293-y.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sahebkar A. A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin Nutr. 2014 Jun 1;33(3):406–14.
Article
CAS
PubMed
Google Scholar
Li ZL, Xu L, Sun XR, Guo FF, Gong YL, Gao SL. Central nesfatin-1 influences the excitability of ghrelin-responsive gastric distension neurons in the arcuate nucleus and reduces gastric motility in rats. Eur J Neurosci. 2013 Dec 1;38(11):3636–43.
Article
PubMed
Google Scholar
Veghari G, Sedaghat M, Joshaghani H, Banihashem S, Moharloei P, Angizeh A, Tazik E, Moghaddami A, Hajian-Tilaki K, ZahedPasha Y. The association of fasting blood glucose (FBG) and waist circumference in northern adults in Iran: a population-based study. Journal of Diabetes & Metabolic Disorders 2014 Dec;13(1):2. http://www.jdmdonline.com/content/13/1/2
Ramesh N, Gawli K, Kiran Pasupulleti V, Unniappan S. Metabolic and cardiovascular actions of nesfatin-1: implications in health and disease. Curr Pharm Des. 2017 Mar 1;23(10):1453–64.
Article
CAS
PubMed
Google Scholar
Yin Y, Li Z, Gao L, Li Y, Zhao J, Zhang W. AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1. Mol Cell Endocrinol. 2015 Dec 5;417:20–6.
Article
CAS
PubMed
Google Scholar
Catak Z, Aydin S, Sahin İ, Kuloglu T, Aksoy A, Dagli AF. Regulatory neuropeptides (ghrelin, obestatin, and nesfatin-1) levels in serum and reproductive tissues of female and male rats with the fructose-induced metabolic syndrome. Neuropeptides. 2014 Jun 1;48(3):167–77.
Article
CAS
PubMed
Google Scholar
Mohanna S, Baracco R, Seclén S. Lipid profile, waist circumference, and body mass index in a high altitude population. High Alt Med Biol. 2006 Sep 1;7(3):245–55.
Article
CAS
PubMed
Google Scholar
Kang HT, Yoon JH, Kim JY, Ahn SK, Linton JA, Koh SB, Kim JK. The association between the ratio of triglyceride to HDL-C and insulin resistance according to waist circumference in a rural Korean population. Nutr Metab Cardiovasc Dis. 2012 Dec 1;22(12):1054–60.
Article
CAS
PubMed
Google Scholar
Sengupta M, Sharma GD, Chakraborty B. Hepatoprotective and immunomodulatory properties of aqueous extract of Curcuma longa in carbon tetrachloride intoxicated Swiss albino mice. Asian Pacific journal of tropical biomedicine. 2011 Jun 1;1(3):193–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009 Jun;14(2):141–53.
PubMed
Google Scholar
Ghandadi M, Sahebkar A. Curcumin: an effective inhibitor of interleukin-6. Curr Pharm Des. 2017 Feb 1;23(6):921–31.
Article
CAS
PubMed
Google Scholar
Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008 Jun 1;65(11):1631–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Derosa G, Maffioli P, Simental-Mendía LE, Bo S, Sahebkar A. Effect of curcumin on circulating interleukin-6 concentrations: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016 Sep 1;111:394–404.
Article
CAS
PubMed
Google Scholar
Jacob A, Wu R, Zhou M, Wang P. Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-γ Activation. PPAR Research 2007; Article ID: 89369. 5 pages. doi:https://doi.org/10.1155/2007/89369.
Tang CH, Fu XJ, Xu XL, Wei XJ, Pan HS. The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain. Peptides. 2012 Jul 1;36(1):39–45.
Article
CAS
PubMed
Google Scholar
Kolgazi M, Cantali-Ozturk C, Deniz R, Ozdemir-Kumral ZN, Yuksel M, Sirvanci S, Yeğen BC. Nesfatin-1 alleviates gastric damage via direct antioxidant mechanisms. journal of surgical research. 2015 Jan 1;193(1):111–8.
Article
CAS
PubMed
Google Scholar
Shirvani H, Ghanbari-Niaki A, Rahmati-Ahmadabad S. Effects of endurance training and herb supplementation on tissue nesfatin-1/nucleobindin-2 and ghrelin mRNA expression. International Journal of Applied Exercise Physiology. 2017 Apr 27;6(1):71–84.
Article
Google Scholar
Afrin R, Arumugam S, Rahman A, Wahed MI, Karuppagounder V, Harima M, Suzuki H, Miyashita S, Suzuki K, Yoneyama H, Ueno K. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation. Int Immunopharmacol. 2017 Mar 1;44:174–82.
Article
CAS
PubMed
Google Scholar
Bao W, Li K, Rong S, Yao P, Hao L, Ying C, Zhang X, Nussler A, Liu L. Curcumin alleviates ethanol-induced hepatocytes oxidative damage involving heme oxygenase-1 induction. J Ethnopharmacol. 2010 Mar 24;128(2):549–53.
Article
CAS
PubMed
Google Scholar
Chi X, Yu D, Li P, Lu Q, Jiang W, Hao K. The protective effects of (1E, 6E)-1, 7-diphenylhepta-1, 6-diene-3, 5-dione, a curcumin analogue, against operative liver injury in rats. Eur J Pharm Sci. 2017 Mar 30;100:94–101.
Article
CAS
PubMed
Google Scholar
Guo C, Ma J, Zhong Q, Zhao M, Hu T, Chen T, Qiu L, Wen L. Curcumin improves alcoholic fatty liver by inhibiting fatty acid biosynthesis. Toxicol Appl Pharmacol. 2017 Aug 1;328:1–9.
Article
CAS
PubMed
Google Scholar